1. Home
  2. MDA vs STVN Comparison

MDA vs STVN Comparison

Compare MDA & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MDA

MDA Space Ltd. Common Shares

N/A

Current Price

$29.08

Market Cap

4.2B

ML Signal

N/A

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$16.29

Market Cap

3.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDA
STVN
Founded
1969
1949
Country
Canada
Italy
Employees
4000
N/A
Industry
Electronic Components
Containers/Packaging
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.7B
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
MDA
STVN
Price
$29.08
$16.29
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$37.50
$25.67
AVG Volume (30 Days)
652.5K
575.1K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
0.39%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.11
$9.67
Revenue Next Year
$11.03
$9.99
P/E Ratio
N/A
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$23.23
$12.89
52 Week High
$37.45
$28.00

Technical Indicators

Market Signals
Indicator
MDA
STVN
Relative Strength Index (RSI) 39.94 65.08
Support Level $23.23 $13.58
Resistance Level $33.75 $16.69
Average True Range (ATR) 1.67 0.76
MACD -0.38 0.23
Stochastic Oscillator 1.12 74.29

Price Performance

Historical Comparison
MDA
STVN

About MDA MDA Space Ltd. Common Shares

MDA Space Ltd is a developer and manufacturer of technology and services to the space industry. It is an international space mission partner and robotics, satellite systems, and geo-intelligence pioneer. It is engaged in communications satellites, Earth and space observation, space exploration, and infrastructure. The Company collaborates and partners with governments and space agencies, commercial space companies, and defence and aerospace prime contractors in the space industry. Geographically, it generates the majority of its revenue from Canada.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: